TDAC Stock: Translational Development Acquisition Corp. Stock Price, Analysis & Insights
Get live TDAC stock price $10.72, comprehensive Translational Development Acquisition Corp. stock analysis, charts, news, and expert forecast. Real-time TDAC stock data and investment insights.
Loading chart data...
Translational Development Acquisition Corp. (TDAC) Overview
Translational Development Acquisition Corp. (TDAC) is a publicly traded company in the Financial Services sector , specifically within the Shell Companies industry . As of the latest trading session, TDAC trades at $10.72 with a market capitalization of 234.85M . Over the past 52 weeks, TDAC has traded between $10.25 and $10.80 , with the current price positioned at approximately 86% of this ra...
Key Takeaways
- Operates in the Financial Services sector (Shell Companies)
- Market cap: 234.85M
- Current price: $10.72
- 52-week range: $10.25 - $10.80
- P/E ratio: 38.29
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share...
Company Information
- CEO
- Michael Hoffman
- Sector
- Financial Services
- Industry
- Shell Companies
- Employees
- 2
Contact Information
- Address
- 77 Water St Fl 8
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 38.3)
✓ Lower volatility stock (Beta: 0.01) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Translational Development Acquisition Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Translational Development Acquisition Corp.
- ⚠Investors should consider how Translational Development Acquisition Corp. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 38.3) requires strong growth to justify
Market Cap
234.85M
P/E Ratio (TTM)
38.29
Beta
0.01
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare TDAC with peer companies:
- Price
- $14.27
- Market cap
- 178.38M
- Price
- $10.62
- Market cap
- 217.71M
- Price
- $10.66
- Market cap
- 259.27M
- Price
- $10.26
- Market cap
- 135.27M
- Price
- $10.86
- Market cap
- 234.81M
- Price
- $10.63
- Market cap
- 191.32M
- Price
- $10.35
- Market cap
- 244.26M
- Price
- $28.38
- Market cap
- 359.01M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.